Clin2
NCT07577999Possibly a fitNot yet recruiting

Cannabis-based medication to improve recovery after bladder cancer surgery

Non-metastatic Bladder Cancer

Part of Cancer, Kidney & urinary clinical trials.

This study tests whether a cannabis-based medication (cannabigerol, a non-psychoactive compound) helps improve recovery after surgery to remove the bladder. Participants will take the medication during the post-surgery period, and the study will monitor pain, recovery, and any side effects.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
20 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years old or older.
  • You have non-metastatic bladder cancer and are scheduled for radical cystectomy (removal of the bladder) with urinary diversion (a way to drain urine).
  • You live in California.
  • You have not used cannabis, CBD, or THC products in the last 30 days and can agree not to use any cannabis products during the study.
  • You do not have a history of substance abuse, psychosis, or schizophrenia.
  • You have not had a heart attack or related heart condition in the last 90 days.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT03193970Recruiting
Study recovery after bladder removal surgery

This trial looks at how patients recover after radical cystectomy, a surgery that removes the bladder for bladder cancer. It will study recovery patterns to help understand what recovery may look like and possibly improve care.

Stanford, California
NCT07545694Recruiting
Bladder Drug Study for Cancer Patients Undergoing Surgery

This study tests how certain drugs affecting the endocannabinoid system (a natural body signaling pathway) affect bladder muscle function in people with bladder cancer who are preparing for or undergoing surgery. Researchers hope this research will help preserve bladder function during cancer treatment.

Rome
NCT07658677Not yet recruiting· Phase 1/Phase 2
Cannabis gummy for improving sleep in cancer patients

This study tests whether a cannabis gummy can improve sleep and quality of life for people with cancer. You would take a gummy nightly, wear a fitness tracker, and answer short surveys about your sleep and well-being.

Columbus, Ohio
NCT06261489Recruiting· Phase 2
Cannabis for bladder problems in multiple sclerosis

This study tests whether cannabis, with either THC or CBD, helps with bladder and urinary symptoms caused by multiple sclerosis. It compares two types of cannabis to see which works better.

Calgary, Alberta
NCT06266611Recruiting· Phase 2
Cannabis for cancer symptom relief

This trial tests whether cannabis can help cancer patients manage symptoms like sleep trouble, pain, and mood changes. It's for people who are new to using cannabis for these issues.

Aurora, Colorado
NCT07459920Not yet recruiting· Phase 2
Cannabis extract for cancer-related symptoms

This trial tests whether a cannabis extract can help reduce symptoms like pain, nausea, anxiety, and poor appetite in people with advanced cancer. If you are already on strong pain medication and struggling with these symptoms, this study aims to see if adding cannabis improves your quality of life.

Naples

Hear when a new Non-metastatic Bladder Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.